Decentralized clinical trial company THREAD announced Tuesday it has acquired CureClick, a platform for recruiting trial participants.
The latest deal is THREAD's third acquisition announcement in less than six months. In January, the company said it had scooped up inVibe, which aims to use patient voice data for research. THREAD also acquired Modus Outcomes, a research design consultancy, in...
The first technology-enabled remote clinical trial was launched nearly a decade ago, and that field – now generally referred to as "decentralized clinical trials" – has been advancing and gaining traction ever since. But, like so many other remote tools, it's been greatly accelerated by the COVID-19 pandemic.
On today's HIMSSCast, host Jonah Comstock and MobiHealthNews Managing Editor Laura...
Yesterday private equity firms Water Street Health Partners and JLL Partners announced that they had acquired virtual clinical research company Thread for an undisclosed amount. The new owners say they plan on investing in Thread in order to further expand its customer base and offer the platform on a global scale.
Thread’s platform is aimed at improving clinical trial research data and making...
Dr. Mehmet Oz, a well-known television personality, has joined health technology startup iBeat as Special Advisor, in addition to making an investment in the company. The company makes a not-yet-launched smartwatch that offers continuous monitoring and analysis of heart rate, working to instantly detect signs of oncoming cardiac arrest. Oz, after reportedly seeing the potential impact of the...
Johns Hopkins University is preparing to launch the first Apple ResearchKit study to incorporate the Apple Watch as a data collection device, according to a report from Apple Insider. Johns Hopkins declined to comment at this time.
The study will be designed to help Johns Hopkins researchers learn more about epilepsy, according to the report. Johns Hopkins will work with Thread Research, who also...
